A A A

Development times

By Project team , on 1 June 2014

Based on information users provide on the type of projects they are working on (i.e. type of source material, therapeutic focus), the BRITS tool provides average development times for comparable projects. The BRITS team formulated estimates of development times for different types of cell therapy projects by matching data on cell therapy projects from Citeline Pharmaprojects with data on clinical trials associated with these projects that were downloaded from www.clinicaltrials.gov. For the 305 clinical trials on which the BRITS team was able to identify a start and end date of the trials the total duration of trials was calculated. Figure 7 highlights the average development times at different stages for allogeneic and autologous cell therapies.

 

Figure 7: Development times for cell therapy projects

Screen Shot 2014-06-27 at 17.06.49